학술논문

Phase I clinical trial of recombinant human interleukin-3 combined with carboplatin in the treatment of patients with recurrent ovarian carcinoma.
Document Type
journal article
Source
JNCI: Journal of the National Cancer Institute; 5/19/1993, Vol. 85 Issue 10, p823-825, 3p
Subject
CANCER relapse
CLINICAL trials
COMPARATIVE studies
INTERLEUKIN-3
RESEARCH methodology
MEDICAL cooperation
NEUTROPHILS
OVARIAN tumors
RECOMBINANT proteins
RESEARCH
EVALUATION research
CARBOPLATIN
PLATELET count
Language
ISSN
00278874